Literature DB >> 28133774

Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis.

Yan Wang1, Robert Vincent2, Jinlian Yang1, Amon Asgharpour2, Xieer Liang1, Michael O Idowu3, Melissa J Contos3, Kalyani Daitya2, Mohammed S Siddiqui2, Faridoddin Mirshahi2, Arun J Sanyal2.   

Abstract

There is a need for further refinement of current histological systems for assessment of hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD). This study evaluated hepatic fibrosis in NAFLD using dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FPs). Fifty test cohort subjects and 42 validation cohort subjects with NAFLD and the full spectrum of fibrosis were studied. q-FPs were measured in specific predefined regions of interest (general, vessel, perisinusoid, and vascular septa). Seventy q-FPs had inter- and intraobserver concordance ≥0.8 and were related to the NASH Clinical Research Network fibrosis staging. Of these, 16 q-FPs with the strongest correlations (P < 0.001 for all) were entered in a principal component analysis model (odds ratio [OR] 7.8, P < 0.001), which separated any stage of fibrosis versus no fibrosis, and cirrhosis versus earlier stages with the areas under the receiver operating characteristic curves of 0.88 and 0.93 (P ≤ 0.01 for both), respectively. In an independent multivariable analysis, four q-FPs-the number of collagen strands (OR 8.5, P = 0.004), strand length (OR 12.0, P = 0.02), strand eccentricity (OR 8.3, P = 0.004), and strand solidity (OR 8.0, P = 0.003)-were independently associated with fibrosis stages and were used to model fibrosis along a continuous linear scale using desirability functions; this linear scale of fibrosis measurement was also related to fibrosis stage (P < 0.0001). The robustness of both the multivariable model and the linear scale of measurement was confirmed in the validation cohort.
CONCLUSION: The q-FP model provides an accurate reproducible method to evaluate fibrosis in NAFLD along a quantitative and continuous scale. (Hepatology 2017;65:1891-1903).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 28133774      PMCID: PMC5444965          DOI: 10.1002/hep.29090

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Arun J Sanyal; Veronica Miller
Journal:  Gastroenterology       Date:  2016-02-26       Impact factor: 22.682

2.  An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C.

Authors:  M J O'Brien; N M Keating; S Elderiny; S Cerda; A P Keaveny; N H Afdhal; D P Nunes
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

3.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

4.  Experimental design and desirability function approach for development of novel anticancer nanocarrier delivery systems.

Authors:  H Rafati; F Mirzajani
Journal:  Pharmazie       Date:  2011-01       Impact factor: 1.267

5.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

Authors:  Z M Younossi; T Gramlich; Y C Liu; C Matteoni; M Petrelli; J Goldblum; L Rybicki; A J McCullough
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

6.  Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors.

Authors:  Kang Mo Kim; Won-Beom Choi; Seong Ho Park; Eunsil Yu; Sung Gyu Lee; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Dong-Jin Suh
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

Review 7.  MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.

Authors:  Parambir S Dulai; Claude B Sirlin; Rohit Loomba
Journal:  J Hepatol       Date:  2016-06-14       Impact factor: 25.083

8.  Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

Authors:  Valerio Nobili; Julie Parkes; Gianfranco Bottazzo; Matilde Marcellini; Richard Cross; Daniel Newman; Francesco Vizzutti; Massimo Pinzani; William M Rosenberg
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

9.  Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy.

Authors:  Tong-Hong Wang; Tse-Ching Chen; Xiao Teng; Kung-Hao Liang; Chau-Ting Yeh
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

Review 10.  Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation.

Authors:  Elizabeth M Brunt
Journal:  Int J Mol Sci       Date:  2016-01-13       Impact factor: 5.923

View more
  13 in total

1.  Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis.

Authors:  Archana Rastogi; Nayana Patil; Rakhi Maiwall; Chhagan Bihari; Ananda Soshee; Shiv K Sarin
Journal:  Virchows Arch       Date:  2021-04-02       Impact factor: 4.064

2.  Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).

Authors:  Giada Sebastiani; Keyur Patel; Vlad Ratziu; Jordan J Feld; Brent A Neuschwander-Tetri; Massimo Pinzani; Salvatore Petta; Annalisa Berzigotti; Peter Metrakos; Naglaa Shoukry; Elizabeth M Brunt; An Tang; Jeremy F Cobbold; Jean-Marie Ekoe; Karen Seto; Peter Ghali; Stéphanie Chevalier; Quentin M Anstee; Heather Watson; Harpreet Bajaj; James Stone; Mark G Swain; Alnoor Ramji
Journal:  Can Liver J       Date:  2022-02-04

3.  Autofluorescence Label-Free Imaging of the Liver Reticular Structure.

Authors:  Anna C Croce; Giuseppina Palladini; Andrea Ferrigno; Mariapia Vairetti
Journal:  Methods Mol Biol       Date:  2023

Review 4.  Histological assessment based on liver biopsy: the value and challenges in NASH drug development.

Authors:  Xiao-Fei Tong; Qian-Yi Wang; Xin-Yan Zhao; Ya-Meng Sun; Xiao-Ning Wu; Li-Ling Yang; Zheng-Zhao Lu; Xiao-Juan Ou; Ji-Dong Jia; Hong You
Journal:  Acta Pharmacol Sin       Date:  2022-02-14       Impact factor: 7.169

Review 5.  Current status and challenges in the drug treatment for fibrotic nonalcoholic steatohepatitis.

Authors:  Yi-Wen Shi; Jian-Gao Fan
Journal:  Acta Pharmacol Sin       Date:  2021-12-14       Impact factor: 7.169

6.  Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling.

Authors:  Chih-Yang Hsiao; Xiao Teng; Tung-Hung Su; Po-Huang Lee; Jia-Horng Kao; Kai-Wen Huang
Journal:  Quant Imaging Med Surg       Date:  2021-01

7.  Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Pik Eu Chang; George Boon Bee Goh; Wei Qiang Leow; Liang Shen; Kiat Hon Lim; Chee Kiat Tan
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

8.  Quantification of hepatic steatosis in chronic liver disease using novel automated method of second harmonic generation and two-photon excited fluorescence.

Authors:  George Boon-Bee Goh; Wei Qiang Leow; Shen Liang; Wei Keat Wan; Tony Kiat Hon Lim; Chee Kiat Tan; Pik Eu Chang
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

Review 9.  Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective.

Authors:  Gwyneth Soon; Aileen Wee
Journal:  Clin Mol Hepatol       Date:  2020-11-19

10.  Reliable computational quantification of liver fibrosis is compromised by inherent staining variation.

Authors:  Stuart Astbury; Jane I Grove; David A Dorward; Indra N Guha; Jonathan A Fallowfield; Timothy J Kendall
Journal:  J Pathol Clin Res       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.